review montelukast at four to eight weeks following initiation to ensure a response and that therapy is still required.issue a steroid treatment card to patients on inhaled high dose corticosteroids - steroid emergency card may also be required.reductions in high dose ICS should be considered every three months, decreasing the dose by approximately 25–50% each time, arranging regular review as treatment is reduced.review inappropriate use of high strength corticosteroid inhalers (maintaining patients at the lowest possible dose of inhaled corticosteroid).review patients with asthma who have been prescribed an ICS inhaler and do not currently order on their repeat prescription - assess adherence and understanding of treatment to establish appropriate use of SABA inhalers.review patients with asthma prescribed SABA and LABA without ICS.review patients on SABA inhalers alone, clarifying the diagnosis and establishing reasons for SABA only use.recommend that a patient prescribed six or more inhalers annually is a trigger for timely, priority review - an immediate prescription may be necessary but review should take place before authorisation of the next prescription.11 Summary of recommendations in asthma In all individuals with asthma Asthma accounts for 2-3% of primary care consultations, 60,000 hospital admissions, and 200,000 bed days per year in the UK.
Over five million people are receiving asthmatreatment in the UK.
0 kommentar(er)
